Ethohexadiol

Ethohexadiol

SCHEMBL1230734

CC(C)O.CC(C)O.CCCC(O)C(CC)CO.[AlH3]

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.86
TSHR P16473 2/20 0.42
ALDH1A1 P00352 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP2D6 P10635 2/20 0.32
SPHK1 Q9NYA1 2/20 0.32
GMNN O75496 1/20 0.32
POLB P06746 1/20 0.32
THPO P40225 1/20 0.32
MTOR P42345 1/20 0.32
BLM P54132 1/20 0.32
KDM4E B2RXH2 1/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPT P10636 1/20 0.32
CETP P11597 1/20 0.32
HTT P42858 1/20 0.32
UBE2N P61088 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethohexadiol SCHEMBL2010957 1.00 LMNA (0.86) LMNATSHRALDH1A1TDP1CYP2D6
Ethohexadiol SCHEMBL1229925 0.95 LMNA (0.86) LMNATSHRALDH1A1TDP1CYP2D6
Ethohexadiol SCHEMBL1229592 0.95 LMNA (0.86) LMNATSHRALDH1A1TDP1CYP2D6
Ethohexadiol SCHEMBL6282991 0.93 LMNA (1.00) LMNATSHRALDH1A1TDP1CYP2D6
Ethohexadiol SCHEMBL38007 0.93 LMNA (1.00) LMNATSHRALDH1A1TDP1CYP2D6
Ethohexadiol SCHEMBL9621649 0.91 LMNA (0.86) LMNATSHRALDH1A1TDP1CYP2D6
Ethohexadiol SCHEMBL610774 0.91 LMNA (0.95) LMNATSHRALDH1A1TDP1CYP2D6
Ethohexadiol SCHEMBL10731659 0.91 LMNA (0.95) LMNATSHRALDH1A1TDP1CYP2D6
Ethohexadiol SCHEMBL20787860 0.91 LMNA (0.95) LMNATSHRALDH1A1TDP1CYP2D6
Ethohexadiol SCHEMBL11502837 0.91 LMNA (0.95) LMNATSHRALDH1A1TDP1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1746134-B1 CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS KANEKA CORP (JP) 2019-09-04 EP disclosed
EP-1746135-B1 CURABLE COMPOSITION KANEKA CORP (JP) 2019-05-29 EP disclosed
US-7973108-B2 Curable composition KANEKA CORPORATION (JP) 2011-07-05 US disclosed
WO-2011072056-A2 CURE RATE CONTROL FOR ALKOXYSILYL-END-BLOCKED POLYMERS DOW CORNING COPORATION (US) 2011-06-16 WO disclosed
US-7910681-B2 Curable composition having improved adhesion KANEKA CORPORATION (JP) 2011-03-22 US disclosed
US-7893170-B2 Curable composition having improved curability and adhesion KANEKA CORPORATION (JP) 2011-02-22 US disclosed
US-20080319152-A1 Curable Composition KANEKA CORPORATION (JP) 2008-12-25 US disclosed
US-20080194773-A1 Polysiloxane from silanetriol group, a titanium, aluminum or a zirconium catalyst, and a low molecular weight compound containing a hydrolyzable silicon group; sealants, adhesives KANEKA CORPORATION (JP) 2008-08-14 US disclosed
US-20080076878-A1 Organic polymer having a silane tiol group, a titanium, aluminum or a zirconium catalyst, and a low molecular weight compound containing a hydrolyzable silicon group; sealants, adhesives KANEKA CORPORATION (JP) 2008-03-27 US disclosed
EP-1746134-A1 CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS Kaneka Corporation (JP) 2007-01-24 EP disclosed
EP-1746133-A1 CURABLE COMPOSITION IMPROVED IN ADHESIVENESS Kaneka Corporation (JP) 2007-01-24 EP disclosed
EP-1746135-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2007-01-24 EP disclosed